Yair Lotan

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Primary prevention of nephrolithiasis is cost-effective for a national healthcare system
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    BJU Int 110:E1060-7. 2012
  2. ncbi Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness
    Y Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas Electronic address
    J Urol 189:935-9. 2013
  3. ncbi Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 187:2005-10. 2012
  4. ncbi Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9110, USA
    J Clin Oncol 23:6533-9. 2005
  5. ncbi Economics and cost of care of stone disease
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Adv Chronic Kidney Dis 16:5-10. 2009
  6. ncbi The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    BJU Int 105:1531-5. 2010
  7. ncbi Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Urol Oncol 28:441-8. 2010
  8. ncbi Cost-effectiveness of bladder cancer screening
    Yair Lotan
    Assistant Professor of Urology, Department of Urology, The University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
    Expert Rev Pharmacoecon Outcomes Res 7:627-32. 2007
  9. ncbi Economics of stone management
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, J8 112, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Urol Clin North Am 34:443-53. 2007
  10. ncbi Role of biomarkers to predict outcomes and response to therapy
    Yair Lotan
    Department of Urology, The University of Texas, Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Urol Oncol 28:97-101. 2010

Collaborators

Detail Information

Publications111 found, 100 shown here

  1. ncbi Primary prevention of nephrolithiasis is cost-effective for a national healthcare system
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    BJU Int 110:E1060-7. 2012
    ..Future studies will need to assess the feasibility and effectiveness of such an approach in a population...
  2. ncbi Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness
    Y Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas Electronic address
    J Urol 189:935-9. 2013
    ..We evaluated the economic impact of preventing recurrent stones using a strategy of increased water intake and determined the impact of compliance on cost-effectiveness for the French health care system...
  3. ncbi Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 187:2005-10. 2012
    ..Epidemiological and biological evidence suggests a preventive effect of selenium and vitamin E on bladder cancer. We assessed the effect of selenium and/or vitamin E on bladder cancer development...
  4. ncbi Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9110, USA
    J Clin Oncol 23:6533-9. 2005
    ..We hypothesized that bladder cancer patients with associated lymphovascular invasion (LVI) are at increased risk of occult metastases...
  5. ncbi Economics and cost of care of stone disease
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Adv Chronic Kidney Dis 16:5-10. 2009
    ..These efforts include improving dietary recommendations, identifying barriers to evaluations and treatment of recurrent stone formers, improving patient compliance with recommendations, and development of new medications...
  6. ncbi The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    BJU Int 105:1531-5. 2010
    ....
  7. ncbi Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Urol Oncol 28:441-8. 2010
    ..Moreover, we attempt to outline criteria for the clinical utility of new bladder cancer diagnostic markers...
  8. ncbi Cost-effectiveness of bladder cancer screening
    Yair Lotan
    Assistant Professor of Urology, Department of Urology, The University of Texas, Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
    Expert Rev Pharmacoecon Outcomes Res 7:627-32. 2007
    ..Studies need to be performed to evaluate the feasibility and cost-effectiveness of screening high-risk populations such as smokers...
  9. ncbi Economics of stone management
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, J8 112, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Urol Clin North Am 34:443-53. 2007
    ..For single and recurrent stone formers, medical prophylactic strategies involving drug therapy are more costly than conservative therapy involving dietary measures alone. However, drug strategies yield fewer stone recurrences...
  10. ncbi Role of biomarkers to predict outcomes and response to therapy
    Yair Lotan
    Department of Urology, The University of Texas, Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Urol Oncol 28:97-101. 2010
    ..Furthermore, markers may guide targeted therapy. Prospective trials are needed to validate the clinical benefit of assessing expression patterns of molecular biomarkers...
  11. ncbi Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75309-9110, USA
    Eur Urol 52:453-4. 2007
  12. ncbi Economics of robotics in urology
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Curr Opin Urol 20:92-7. 2010
    ..This review will discuss general concepts of health economics and apply them to the application of robotics to urologic procedures...
  13. ncbi Screening for bladder cancer: a perspective
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
    World J Urol 26:13-8. 2008
    ..In this article, we will review the pros and cons of bladder cancer screening with a focus on cost-effectiveness and who should be screened...
  14. ncbi Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Cancer 115:4096-103. 2009
    ....
  15. ncbi Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 182:52-7; discussion 58. 2009
    ..We evaluated whether screening high risk asymptomatic individuals with a bladder tumor marker can lead to earlier detection and resultant down staging of bladder cancer...
  16. ncbi Are urologists fairly reimbursed for complex procedures: failure of 22 modifier?
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Urology 72:494-7. 2008
    ..The 22 modifier was designed to provide surgeons with additional reimbursement for performing complex procedures. We evaluated whether urologists at a tertiary referral center are reimbursed when using the 22 modifier...
  17. ncbi International comparison of cost effectiveness of medical management strategies for nephrolithiasis
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Urol Res 33:223-30. 2005
    ..The differential resource allocation to different components of a healthcare system (i.e. subsidized medication versus surgical treatment) in different countries determines the cost effectiveness of various treatment strategies...
  18. ncbi Cost-effectiveness of primary prevention strategies for nephrolithiasis
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Urol 186:550-5. 2011
    ..Stone disease is a highly prevalent condition associated with substantial cost and morbidity. We evaluated the cost-effectiveness of a primary prevention strategy...
  19. ncbi The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy
    Yair Lotan
    Departments of Urology and Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    J Urol 171:2209-14. 2004
    ..We examined if the percent of positive biopsies is associated with features of biologically aggressive prostate cancer, biochemical progression and development of distant metastases in patients undergoing radical prostatectomy (RP)...
  20. ncbi The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 172:1431-5. 2004
    ..We evaluated the costs components of laparoscopic (LRP) and robot assisted prostatectomy (RAP), and compared their costs to those of open radical retropubic prostatectomy (RRP)...
  21. ncbi Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    J Urol 179:2164-9. 2008
    ..We prospectively evaluated the clinical usefulness of fluorescence in situ hybridization assay for treating patients with atypical cytology who are at risk for bladder cancer...
  22. ncbi The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Urol 172:1958-62. 2004
    ..We studied the effect of these changes on hourly reimbursement rates for various services provided by urologists...
  23. ncbi Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Cancer Biol Ther 7:101-2. 2008
  24. ncbi Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection
    Yair Lotan
    Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
    BJU Int 101:1362-7. 2008
    ..Newton, MA, USA) for the detection of bladder cancer, as this is a point-of-care assay that measures NMPs in voided urine...
  25. ncbi A cost comparison of nephron-sparing surgical techniques for renal tumour
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    BJU Int 95:1039-42. 2005
    ..To compare costs associated with open partial nephrectomy (OPN), laparoscopic PN (LPN) and percutaneous radiofrequency ablation (PRF) in consecutive patients undergoing nephron-sparing surgery...
  26. ncbi Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
    J Clin Oncol 23:1911-20. 2005
    ..To assess the estimated effect of finasteride prevention of prostate cancer on overall survival...
  27. ncbi Is robotic surgery cost-effective: no
    Yair Lotan
    Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Curr Opin Urol 22:66-9. 2012
    ..This review will evaluate the cost-effectiveness of using robotics in urologic surgery...
  28. ncbi Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    J Urol 182:78-84; discussion 84. 2009
    ..We tested whether the combination of immunohistochemical markers could risk stratify cases of pT1 urothelial carcinoma of the bladder at radical cystectomy...
  29. ncbi Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients
    Amit Gupta
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Eur Urol 55:1124-33. 2009
    ..This axis is involved in cell proliferation, angiogenesis, extracellular matrix degradation, invasion, and metastases...
  30. ncbi Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
    Eugene K Cha
    Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10065, USA
    Eur Urol 61:818-25. 2012
    ..Novel prognostic factors for patients after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) have recently been described...
  31. ncbi Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Urol 176:2414-22; discussion 2422. 2006
    ..We present the characteristics and outcomes of a large, contemporary, consecutive series of patients treated with radical cystectomy and pelvic lymphadenectomy for transitional cell carcinoma of the bladder...
  32. ncbi Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study
    Shahrokh F Shariat
    Departments of Urology and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Clin Cancer Res 15:7012-9. 2009
    ..Specimens showing at least 10% reactivity were considered altered. Predictive accuracy was quantified using the concordance index and 200-bootstrap resamples were used to reduce overfit bias...
  33. ncbi Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Eur Urol 51:152-60. 2007
    ..The aim of this study was to assess whether presence of concomitant CIS has a detrimental effect on cancer control after radical cystectomy...
  34. ncbi Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 10065, USA
    J Urol 183:68-75. 2010
    ..We also assessed whether the combination of molecular markers is superior to any individual biomarker...
  35. ncbi Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    J Urol 183:1744-50. 2010
    ....
  36. ncbi Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts
    Bahaa S Malaeb
    Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
    Urol Oncol 25:291-7. 2007
    ..To evaluate the feasibility of radical retropubic prostatectomy (RRP) as an option for treating men older than 70 years with organ confined prostate cancer and to compare biochemical progression-free survival with younger cohorts...
  37. ncbi Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
    Jose A Karam
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Lancet Oncol 8:128-36. 2007
    ....
  38. ncbi p53 expression in patients with advanced urothelial cancer of the urinary bladder
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    BJU Int 105:489-95. 2010
    ..To test whether assessing p53 expression could improve the ability to predict disease recurrence and disease-specific survival in a multi-institutional cohort of patients with advanced urothelial carcinoma of the urinary bladder (UCB)...
  39. ncbi Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
    Guru Sonpavde
    Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
    BJU Int 108:687-92. 2011
    ..To stratify risk of pathological (p) T2N0 urothelial carcinoma of the bladder after radical cystectomy (RC) based on pathological factors to facilitate the development of adjuvant therapy trials for high-risk patients...
  40. ncbi Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer
    Vitaly Margulis
    Department of Urologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    J Natl Cancer Inst 101:114-9. 2009
    ....
  41. ncbi Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer
    Guru Sonpavde
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    J Urol 185:456-61. 2011
    ..We identified an association between disease-free survival at 2 to 3 years and 5-year overall survival...
  42. ncbi Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence
    Jose A Karam
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Prostate 67:614-22. 2007
    ....
  43. ncbi Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers
    Payal Kapur
    Dept of Pathology, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
    Am J Clin Pathol 135:822-30. 2011
    ..04). Stage, lymph node involvement, combined alterations of p27 and Ki-67, and combined alterations of all 5 biomarkers were associated with increased probability of disease recurrence and cancer-specific mortality (P < .05)...
  44. ncbi Nomograms provide improved accuracy for predicting survival after radical cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, and The Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA
    Clin Cancer Res 12:6663-76. 2006
    ....
  45. ncbi The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma
    Cenk Gurbuz
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Endourol 25:775-9. 2011
    ..Our data support the continued role of ureteroscopic ablation of UTUC in appropriately selected patients...
  46. ncbi Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration
    Ramy F Youssef
    UT Southwestern Medical Center, Dallas, TX, USA
    BJU Int 108:1286-91. 2011
    ..To describe a multicentre experience with preoperative platinum-based chemotherapy before radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC) with loco-regional nodal metastases...
  47. ncbi Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma
    Harun Fajkovic
    Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York 10065, USA
    J Urol 187:845-51. 2012
    ..We assessed the prognostic value of extranodal extension and other lymph node parameters in a large multicenter cohort of patients with lymph node metastasis after radical nephroureterectomy...
  48. ncbi Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine model
    Matthew T Gettman
    Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9110, USA
    J Endourol 16:565-70. 2002
    ..However, histologic evidence of viable cells within the treatment zone mandates refinement of the technique in the animal model before further application in humans. Hilar occlusion does not appear to enhance tissue ablation...
  49. ncbi Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours
    Joshua M Stern
    Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX 75390 9110, USA
    BJU Int 100:287-90. 2007
    ....
  50. ncbi Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease
    Vitaly Margulis
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
    Clin Cancer Res 12:7369-73. 2006
    ..041). CONCLUSIONS: Ki-67 overexpression is associated with features of aggressive bladder TCC and adds independent prognostic information to standard pathologic features for prediction of clinical outcome after radical cystectomy...
  51. ncbi The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy
    Thomas F Chromecki
    Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10065, USA
    Eur Urol 61:245-53. 2012
    ..The prognostic impact of multifocal upper-tract urothelial carcinoma (UTUC) is poorly understood...
  52. ncbi The influence of body mass index on the cost of radical prostatectomy for prostate cancer
    Christian Bolenz
    Departments of Urology, University of Texas Southwestern Medical Center at Dallas, TX, USA
    BJU Int 106:1188-93. 2010
    ..to evaluate the impact of obesity on the costs of robotic-assisted (RALP), laparoscopic (LRP) and open retropubic radical prostatectomy (RRP)...
  53. ncbi Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy
    Shahrokh F Shariat
    University of Texas Southwestern, Dallas, TX, USA
    BJU Int 105:1672-7. 2010
    ..To assess the impact of patient age on outcomes after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC)...
  54. ncbi Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract
    Vitaly Margulis
    Department of Urology, UT Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 184:453-8. 2010
    ..We created a prognostic tool for the accurate preoperative prediction of nonorgan confined upper tract urothelial carcinoma...
  55. ncbi Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer
    Amit Gupta
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Clin Cancer Res 14:7385-90. 2008
    ..We assessed whether preoperative plasma levels of HGF can enhance the accuracy of standard models for predicting pathologic features and clinical outcomes...
  56. ncbi Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Cancer 112:315-25. 2008
    ....
  57. ncbi Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder
    Jose A Karam
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    Urology 70:482-6. 2007
    ..Our objectives were to evaluate the association of survivin expression with the presence of urothelial cell carcinoma of the bladder and clinical outcomes in patients with non-muscle-invasive urothelial cell carcinoma of the bladder...
  58. ncbi The cost of prostate cancer chemoprevention: a decision analysis model
    Robert S Svatek
    The University of Texas Southwestern Medical Center at Dallas, TX 75390-9110, USA
    Cancer Epidemiol Biomarkers Prev 15:1485-9. 2006
    ..Targeting populations at higher risk for developing prostate cancer, however, allows for considerable flexibility in the medication cost to make prostate cancer chemoprevention a more attainable goal...
  59. ncbi Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    BJU Int 101:232-7. 2008
    ....
  60. ncbi Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Mod Pathol 20:445-59. 2007
    ..In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making...
  61. ncbi Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy
    Seyed M Khoddami
    Department of Urology, The University of Texas South-western Medical Center, Dallas, USA
    BJU Int 94:42-6. 2004
    ..Recognising the distinction in GS 7 between predominant 4 vs 3 scores after radical prostatectomy should improve the ability of clinicians to counsel patients. The GS 4 pattern deserves further molecular study...
  62. ncbi Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder
    Jose A Karam
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Clin Cancer Res 13:4400-6. 2007
    ..Little is known about the expression of this gene in urothelial carcinoma of the bladder (UCB). We profiled DOC-2/DAB2 expression in mouse and human normal and neoplastic urothelia...
  63. ncbi Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    Clin Cancer Res 13:5377-84. 2007
    ..We tested the hypothesis that plasma levels of HER2 and/or EGFR are associated with prostate cancer stage and prognosis in patients with clinically localized disease...
  64. ncbi The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma
    Robert S Svatek
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
    J Urol 176:1321-5; discussion 125. 2006
    ..Implications of such clinical and pathological stage discrepancy should be considered when counseling patients and determining therapeutic approaches...
  65. ncbi Laparoscopic partial nephrectomy using holmium laser in a porcine model
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, 75390-9110, USA
    JSLS 8:51-5. 2004
    ..CONCLUSIONS: The Holmium:YAG laser provides an efficacious modality for transecting the kidney in a porcine model. Clinical trials are necessary to determine its role in laparoscopic partial nephrectomy in humans...
  66. ncbi Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Eur Urol 51:137-49; discussion 149-51. 2007
    ..We compared clinical and pathologic staging in a large, contemporary, consecutive series of patients who were treated with radical cystectomy and pelvic lymphadenectomy, and determined the effect of stage discrepancy on outcomes...
  67. ncbi Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Urol 176:919-26; discussion 926. 2006
    ..We assessed variability in the diagnostic performance of NMP22 for detecting recurrence and progression in patients with Ta, T1, and/or CIS transitional cell carcinoma of the bladder in a large international cohort...
  68. ncbi Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder
    Vitaly Margulis
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    J Urol 177:1163-8. 2007
    ....
  69. ncbi Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers
    Shahrokh F Shariat
    Department of Urology, Weill Cornell Medical Center, New York, NY, USA
    J Urol 187:457-62. 2012
    ..We tested whether assessing the expression of cell cycle related proteins (p53, pRB, p21 and p27) could predict clinical outcomes after radical cystectomy in patients with organ confined urothelial carcinoma of the bladder...
  70. ncbi Survivin expression is associated with bladder cancer presence, stage, progression, and mortality
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Texas 75390 9110, USA
    Cancer 109:1106-13. 2007
    ....
  71. ncbi High-risk patients with hematuria are not evaluated according to guideline recommendations
    Keren Elias
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX, USA
    Cancer 116:2954-9. 2010
    ..To determine whether high-risk patients with hematuria receive evaluation according to guideline recommendations...
  72. ncbi General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results
    Amit Gupta
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Endourol 23:1099-105. 2009
    ..We evaluated intermediate-term outcomes of patients undergoing percutaneous contrast-enhanced computed tomography (CT)-guided radiofrequency ablation (RFA) under general anesthesia (GA) at two high-volume centers...
  73. ncbi Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer
    Christian Bolenz
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
    Eur Urol 57:453-8. 2010
    ..Demand and utilization of minimally invasive approaches to radical prostatectomy have increased in recent years, but comparative studies on cost are lacking...
  74. ncbi Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer
    Robert S Svatek
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Cancer 106:1701-7. 2006
    ....
  75. ncbi Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model
    Lance Walsh
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
    Eur Urol 50:795-800; discussion 800. 2006
    ..These results are preliminary--but promising--and encourage further research into this application of ablative hypofractionated radiation for kidney cancer...
  76. ncbi Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
    Amit Gupta
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Urology 71:302-7. 2008
    ..The aim of the present study was to assess the pathologic features and clinical outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma (UCBC) treated with radical cystectomy...
  77. ncbi Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysis
    Kenneth Ogan
    Clinical Center for Minimally Invasive Urologic Cancer Treatment, Dallas, Texas, USA
    J Urol 168:1945-9; discussion 1949. 2002
    ..Our model identifies several measures that can be applied at any institution to render laparoscopic retroperitoneal lymph node dissection economically superior to the open approach...
  78. ncbi Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    J Urol 167:75-9. 2002
    ..This protocol should be evaluated in a prospective randomized trial to determine whether the financial and emotional benefits outweigh any potential drawbacks...
  79. ncbi Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumours
    Karim Bensalah
    Department of Urology, University of Texas South western Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    BJU Int 101:467-71. 2008
    ..To compare the costs and morbidity of laparoscopic radiofrequency ablation (LRFA) and laparoscopic partial nephrectomy (LPN) for treating small localized renal tumours...
  80. ncbi Cost-effective treatment for ureteropelvic junction obstruction: a decision tree analysis
    Matthew T Gettman
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Urol 169:228-32. 2003
    ..However, cost is only 1 of a number of factors that are considered when deciding on an optimal course of treatment...
  81. ncbi Survivin: a promising biomarker for detection and prognosis of bladder cancer
    Vitaly Margulis
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    World J Urol 26:59-65. 2008
    ..These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms...
  82. ncbi Contemporary laparoscopic and open radical retropubic prostatectomy: pathologic outcomes and Kattan postoperative nomograms are equivalent
    Sangtae Park
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Urology 69:118-22. 2007
    ....
  83. ncbi Cost comparison of hand assisted laparoscopic nephrectomy and open nephrectomy: analysis of individual parameters
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Urol 170:752-5. 2003
    ..In response to budgetary pressure at our large county hospital we reviewed the published experience and identified the cost components of HAL that could be targeted to decrease procedure cost...
  84. ncbi Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis
    Robert S Svatek
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Cancer 112:1058-65. 2008
    ..8% (risk reduction) but questions remain regarding the cost-effectiveness of widespread utilization. The purpose of the current analysis was to evaluate the cost-effectiveness of chemoprevention utilizing a quality-of-life adjustment...
  85. ncbi p53 predictive value for pT1-2 N0 disease at radical cystectomy
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA
    J Urol 182:907-13. 2009
    ..We determined whether p53 expression would improve the prediction of disease progression after radical cystectomy for pT1-2N0M0 UCB...
  86. ncbi Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigen
    Robert S Svatek
    Department of Urology, The University of Texas San Antonio, TX, USA
    Cancer Prev Res (Phila) 4:277-83. 2011
    ..8%, but questions remain regarding the cost-effectiveness of widespread utilization. We evaluated the cost utility of chemoprevention using dutasteride in men at elevated risk for CaP...
  87. ncbi Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
    Hum Pathol 37:1568-76. 2006
    ..Cyclin E1 expression stratifies patients with bladder transitional cell carcinoma into those with more "indolent" behavior and those with features of biologically and clinically aggressive disease...
  88. ncbi Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
    J Urol 174:2046-50. 2005
    ..CONCLUSIONS: Survivin is over expressed in BPH and it correlates with BPH parameters. Increases in proliferation and inhibition of apoptosis have a role in BPH...
  89. ncbi Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, 75390 9110, USA
    Eur Urol 48:424-31. 2005
    ....
  90. ncbi Mesh kits for anterior vaginal prolapse are not cost effective
    Sunshine Murray
    Department of Urology, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 9110, USA
    Int Urogynecol J 22:447-52. 2011
    ..To analyze the cost-effectiveness of traditional anterior colporrhaphy (AC), hand-cut mesh, and mesh kit anterior vaginal prolapse (AVP) repair...
  91. ncbi Nomograms for bladder cancer
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Eur Urol 54:41-53. 2008
    ..Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials...
  92. ncbi Survivin expression is associated with features of biologically aggressive prostate carcinoma
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 91120, USA
    Cancer 100:751-7. 2004
    ....
  93. ncbi Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Cancer 107:982-90. 2006
    ..The U.S. Food and Drug Administration recently approved screening high-risk patients for bladder cancer using urine-based markers. The cost and life-years saved associated with bladder cancer screening were evaluated...
  94. ncbi Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9110, USA
    Urol Oncol 25:468-75. 2007
    ..To determine the association of cyclin D1 and E1 expression with bladder cancer presence, clinical and molecular characteristics, and disease progression in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder...
  95. ncbi Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical School, Dallas, Texas 75390 9110, USA
    Urology 66:1319. 2005
    ..He underwent ileal enterectomy, radical orchiectomy, and several cycles of chemotherapy (cisplatin, etoposide, and bleomycin). He died within 41 days of diagnosis...
  96. ncbi Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center at Dallas, TX 75390 9110, USA
    Eur Urol 49:293-302. 2006
    ..To evaluate the association of total prostate specific antigen (T-PSA) and percent free PSA (%F-PSA) with prostate cancer outcomes in patients treated with radical prostatectomy (RP)...
  97. ncbi Open to debate. The motion: prevention of prostate cancer with a 5alpha-reductase inhibitor is feasible
    Claus G Roehrborn
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
    Eur Urol 49:396-400. 2006
  98. ncbi Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 177:481-7; discussion 487. 2007
    ..We determined whether the combined expression of p53, p21, p27 and pRB is associated with outcomes of patients with nonmuscle invasive bladder transitional cell carcinoma...
  99. ncbi Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 173:1518-25. 2005
    ..We developed and validated nomograms that accurately predict disease recurrence and progression in patients with Ta, T1, or CIS transitional cell carcinoma (TCC) of the bladder using a large international cohort...
  100. ncbi Cost comparison for laparoscopic nephrectomy and open nephrectomy: analysis of individual parameters
    Yair Lotan
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, 75390, USA
    Urology 59:821-5. 2002
    ..LN is cost effective compared with ON if short operating times and brief length of stays are achieved...
  101. ncbi Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma
    Georg C Hutterer
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
    BJU Int 101:561-5. 2008
    ..To assess the value of nuclear matrix protein-22 (NMP22), compared with urinary cytology, in predicting the recurrence of bladder cancer that is not transitional cell carcinoma (non-TCC)...